Nasdaq has added a monetary operations portal to its cloud-based reserves services as part of its growing integrated suite ...

AstraZeneca Plc (NASDAQ:AZN) released high-level results from the CALYPSO Phase 3 trial designed to evaluate the efficacy and ...

LONDON, UK I March 17, 2025 I High-level results from the CALYPSO Phase III trial showed that eneboparatide (AZP-3601), an investigational parathyroid hormone (PTH) receptor 1 agonist, met its primary ...

JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...

CALYPSO is a global Phase III ... It is headquartered in Boston, US. AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, ...

Artificial intelligence (AI) stocks scored massive wins for investors last year and led the Nasdaq to a double-digit gain. This momentum continued into the early days of 2025, but in recent weeks ...

It's been downright nerve-wracking. The Nasdaq Composite (NASDAQINDEX: ^IXIC) has fallen 12% in just three weeks. That's not just a fall into correction territory -- it's the kind of rapid loss ...

Should You Load Up on Shares Now? The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. With headquarters in the ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...

It's been another rough week for U.S. stocks. Both the S&P 500 and Nasdaq Composite were on track to surpass their losses from last week to tally their worst weekly showing since September 2024.

In early trading on Thursday, shares of Intel topped the list of the day's best performing components of the Nasdaq 100 index, trading up 17.0%. Year to date, Intel registers a 20.6% gain.

Maywood Acquisition Corp. (Nasdaq: MAYAU), a Special Purpose Acquisition Company focused on creating long-term value through strategic capital deployment, market access, and industry expertise.